chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After I got the first dose, my left arm was sore and I had a rash that was raised. It was red and warm to the touch. These symptoms persisted and did not go away. About 8-9 days later, I also developed a burn like rash with liquid filled water blisters. I did go see my doctor. I received a Kenalog shot and I was advised not to get the 2nd Moderna vaccine. The Kenalog shot did help to resolve the rash but it took a long time. I still have scarring from the rash.
Headache, pain and soreness at injection site that makes it difficult to move left arm, joint pain in hips and knees, fatigue, overall abdominal pain
Tingling in feet after 1st dose; Sharp pains in hands and feet after 1st dose; Tingling in hands after 1st dose; Rash on feet /hands after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in feet after 1st dose), VACCINATION SITE PAIN (Sharp pains in hands and feet after 1st dose), PARAESTHESIA (Tingling in hands after 1st dose) and RASH (Rash on feet /hands after 1st dose) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031a217) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling in feet after 1st dose), VACCINATION SITE PAIN (Sharp pains in hands and feet after 1st dose), PARAESTHESIA (Tingling in hands after 1st dose) and RASH (Rash on feet /hands after 1st dose). The patient was treated with OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Pain in hand, Rash and Tingling feet/hands, at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (Tingling in feet after 1st dose), VACCINATION SITE PAIN (Sharp pains in hands and feet after 1st dose), PARAESTHESIA (Tingling in hands after 1st dose) and RASH (Rash on feet /hands after 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up received contain significant information and outcome of event updated from unknown to recovered.
This spontaneous report was received from a licensed practical nurse and refers to a 12 year old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 31-AUG-2015, the patient was vaccinated with a dose of GARDASIL (lot # K004204, expiration date 12-JAN-2017; dose and route were not provided) that had experienced an excursion. No adverse reaction was reported. This is one of several reports received from the same reporter. Additional information has been requested.
I started getting a migraine in the evening, approx. 6.5 hrs after I got vaccinated.  My migraine lasted literally 6 days.; neither Ibuprofen nor Sumatriptan helped at all.  3 days after getting vaccinated I woke up absolutely drenched in a cold sweat, I had to change my clothes.  I think it is vaccine related as a friend reported the same thing happened to her after she received the new vax.  Other than that, I experienced standard and expected swelling and soreness in my vaccinated arm and my armpit.
on 5/10/2008 Adnitted to Hospital for vomitting and diarrhea, bloody stools. Abd ultrasound consisitent with Ileocolic Intussusception! Air Reduction Kit utilized and no obstruction and a successdul reduction if the intussusception done. Patient was in the hospital for 4 days 6/20/08-records received for Dos 5/8-5/13/08- DC DX:Ileocecal Intussusception. Therapeutic air contrast enema for reduction was successful. Admitted with nausea and vomiting, on 3rd day of hospitalization episodic crying and attacks of abdominal pain, more vomiting.  Abdomen distended. Hypoactive bowel sounds
Fever 103.4, axillary lymph node size of an orange, symptoms beginning with slight headache proceeded on to high temp for 24 hours and enlarged lymph node interfering with activities of daily living.
Information has been received from a physician concerning a 5 year old female patient. The patient's medical history and concurrent condition were not provided. In approximately 2012 (reported as "at one year of age"), the patient was vaccinated with VARIVAX (lot number, expiration date, route and dose unknown). The concomitant therapy was not provided. On an unspecified date, the patient experienced peanut allergy. On 21-JUL-2016, the patient was exposed to peanuts and experienced a mild anaphylactic reaction, on the same day, the patient received DECADRON 4mg and would begin prednisolone (manufacture unknown) 25mg, twice a day, for two days and then prednisolone 12.5mg, twice a day, for two days. The outcome of peanut allergy and anaphylactic reaction was unknown. The physician considered the events was not related to VARIVAX. Upon internal review, anaphylactic reaction was considered as medically significant. Additional information is not expected as the physician did not want to be contacted.
She didn't get her 2nd dose; Migraine; This is a spontaneous report from a Pfizer-sponsored program Pfizer First Connect. A contactable female consumer (patient) a female patient of an unspecified age received bnt162b2 (BNT162B2, Pfizer-BioNTech Covid-19 mRNA Vaccine, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 2021 as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date in 2021 patient experienced she didn't get her 2nd dose, migraine. Caller lives in an assisted living center and she got her 1st dose 3 weeks ago. Last week she went to her HCP and they put her on quarantine and yesterday came back to give 2nd doses. She spoke to who then informed her they would not be back until next month and she didn't get her 2nd dose. She wanted to know if she would have to start all over again. She also stated she had a migraine. Declined PMI number and cold transferred to PSCC for AE due to wait times, since caller won't be getting her 2nd dose until next month now and she has a migraine.  CEP 2191. The outcome of both events was unknown.  Information on lot/batch number has been requested.  Follow-up attempts are completed. No further information is expected.
No additional AE reported; expired MMRII on 03/01/2023; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's medical history, historical drugs, past drug reactions or allergies, concurrent conditions, and concomitant drugs were not reported.   On 01-MAR-2023, the patient was vaccinated with Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (rHA) subcutaneous injection (lot#: U006485, expiration date: 26-FEB-2023; strength, dose, route of administration, and anatomical location were not reported) for prophylaxis (expired product administered). No additional adverse events (AE) were reported (no adverse event).
patient had a syncopal episode at time of injection. lasted <10 seconds. Also reporting due to patient age 17 years old. Patient stated she thought she could take vaccine so she registered for it.
I started feeling ill cough congestion went to clinic had my lungs check and covid swab, left town on trip went to urgent care diagnosed with pneumonia  received medication for 10 ten days.  I returned home and was check out by my doctor with no more symptoms.
Mom states that shortly after returning home with pt after 1st series of immunizations he cried for close to 2 hours. Calming down. No symptoms of convulsions, high fever, listlessness noted. MD notified 4/30/03.
Patient has been sick; out of body experiance; has hard time breathing; has metallic taste in his mouth; he can hardly walk; hard time staying awake; his hands bother him; confused; he couldn't think; missed work for few weeks; his legs hurt; He has the side effects of COVID; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth) and GAIT DISTURBANCE (he can hardly walk) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID). The patient was treated with PREDNISONE at an unspecified dose and frequency and IBUPROFEN at an unspecified dose and frequency. At the time of the report, ILLNESS (Patient has been sick), FEELING ABNORMAL (out of body experiance), DYSPNOEA (has hard time breathing), AGEUSIA (has metallic taste in his mouth), GAIT DISTURBANCE (he can hardly walk), HYPERSOMNIA (hard time staying awake), LIMB DISCOMFORT (his hands bother him), CONFUSIONAL STATE (confused), THINKING ABNORMAL (he couldn't think), IMPAIRED WORK ABILITY (missed work for few weeks), PAIN IN EXTREMITY (his legs hurt) and VACCINATION COMPLICATION (He has the side effects of COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  Other treatment medications include inhaler and acid reflux medication.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: Follow up received on 26MAY2021, contains non significant information.
03/15/21 @3:30AM awoke with significant headache and vertigo, room spinning around me, could not lay flat. By about 7:00AM vertigo stopped, had HA, dizziness with loss of balance. Ibuprofen 400mg q3-4 hrs, sudafed 30mg q4 hrs. Continued unchanged x 48 hrs. Today, 03/17/21, HA, dizziness, loss of balance somewhat improved, still taking ibuprofen 400mg every 4-5 hrs . Had covid in January 2021 with HA and vertigo as presenting symptoms.
72 hrs, same side as shot right, right ear lobe and behind right ear, swelling, warm to touch, painful ear lobe throbbing. Have had previously received all COVID series and boosters from Pfizer with only side effects sore arm. Last booster was administer Oct 13 2022 along with flu vaccine.  As of this submission which is 12 hrs from initial, pain and swelling seems to be less.   This is new symptom for me.
Information has been received on 02-JUL-2018 regarding a case in litigation from a lawyer and a male consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. On or about 20-JUL-2012, the patient was inoculated with ZOSTAVAX (lot number and expiration unknown) unknown route by a physician, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 18-JUL-2016, the patient was treated at an Emergency care for a severe vesicular outbreak, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX and/or despite receiving the ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Pt was given a pediatric pfizer that was not reconstituted with diluent; no SE thus far per mother
Weakness; confusion; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), CONFUSIONAL STATE (confusion) and FATIGUE (tiredness) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced ASTHENIA (Weakness), CONFUSIONAL STATE (confusion) and FATIGUE (tiredness). On 09-Apr-2021, ASTHENIA (Weakness), CONFUSIONAL STATE (confusion) and FATIGUE (tiredness) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment medications were provide No concomitant medications were reported.   This case was linked to MOD-2021-119177 (Patient Link).
Moderna Covid-19 Vaccine EUA  I week after vaccine  a very large itchy rash on left shoulder around vaccine site. has lasted two days so far
Since vax pt complained of lateral pain deltoid area w/abduction persisting to 09May97.
Bells palsy; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PARALYSIS (Bells palsy) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included OXYBATE SODIUM (XYREM), PIMOZIDE (ORAP), METFORMIN and VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced FACIAL PARALYSIS (Bells palsy) (seriousness criterion medically significant). At the time of the report, FACIAL PARALYSIS (Bells palsy) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment for the event included Amantadine and Methylprednisolone. She was on treatment for that and will be still on treatment during her 2nd dose.  Company comment:Based on the current available information and temporal association between the use of the product and the onset date of the reported event of facial paralysis, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported event of facial paralysis, a causal relationship cannot be excluded.
swelling, deep redness around arm Rt, pain, warm of whole arm diagnosed as "cellulitis"
Rash developing approx 24 hrs after injection. Large reddened, slightly elevated lesion at injection site. Numerous, small, reddened, slightly elevated lesions of arms, forearms, thighs & itching.
This spontaneous report as received from a medical assistant refers to a 2 months old patient of unknown gender. On 19-OCT-2015, the patient was vaccinated with improperly stored dose of ROTATEQ lot # K022995 (dose, route and frequency unspecified). No adverse events were noted. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report was received from the mother of a male patient of unknown age. On an unknown date the patient was vaccinated with GARDASIL dose 1. It was reported that the patient missed the second dose of GARDASIL. No adverse event symptoms reported. No product quality complaint was reported. Additional information has been requested.
Hives on Left Arm and Chest, took Benadryl 50mg Q4-6hrs without relief.
Had no symptoms prior to injection. After injection, quickly developed moderate pain at injection site that eventually became severe. Over the rest of the day, developed a severe headache, severe muscle aches (not just at injection site), severe fatigue, fever of 100.6F, moderate joint aches (not just in arm, but all over body - neck is worst), and general weakness (I almost fell walking to the bathroom and I'm in decently good shape). Toward the evening, I started struggling with thermal homeostasis - I was simultaneously sweating and shivering. The combination of these was severe enough that I had extreme difficulty sleeping last night and woke up at least once an hour, getting <6 hours of sleep after lying in bed for almost 12 hours. Right now (23h post vaccination), the pain at the injection site has gotten significantly less bad, but I still have a splitting headache, fever of 100.3F,  moderate fatigue/weakness, and mild muscle/joint pains across my whole body. I'm unsure how much the headache this morning is from sleep deprivation.   At no point did I lose sense of smell or taste, have a sore throat, cough, runny nose/nasal congestion, or shortness of breath.
About 5 mins after Td & MMR -> lightheaded, nausea, vomiting. Heart rate decreased 67. BP decreased 95/60 from 120/60 earlier. After about 20 mins reclining, was ambulatory & felt better. No rash, respiratory symptoms.
Fever, elevated heart rate 30+ point above normal. Stomach pains and stomach cramps. Fatigue. Back aches. Overall bad feeling. Rare chest pain.
Information has been received from a medical assistant concerning a patient who was vaccinated with a dose of 0.5ml of PNEUMOVAX 23 (Lot# 665925/0932Z) (Exp 07/18/2011), IM right arm. The medical assistant stated that on unspecified date the patient developed a lump and a big red spot at the injection site that traveled down the whole right arm 24 hours post vaccination. All drop down boxes apply to all five patients. At the time of the report the patient outcome was unknown, there were no diagnostics studies performed. The patient sought unspecified medical attention. A standard lot check investigation has been finalized. All in-process quality checks for the lot number in question were satisfactory. The lot met the requirements of the Center for Biologics Evaluation and Research and was released. Follow up information has been received from the medical assistant concerning the 74 year old female retired patient with no illness at time of vaccination and no adverse events following prior vaccination and with hypothyroidism, hypertension, dyslipidemia, atrial fibrillation and pulmonary hypertension who on 13-OCT-2010 at morning was vaccinated intramuscular in the left upper extremity with the first dose of PNEUMOVAX 23 (Lot# 665925/0932Z). Concomitantly on the same day, the patient received intramuscularly in the right upper extremity a first dose of FLUARIX (Lot# AFLLA616AA). On 14-OCT-2010, a large erythematous rash was noted on lateral aspect of left arm from mid deltoid recessed to elbow. No fever or infection. There were no laboratory tests or diagnostic studies performed. On 22-OCT-2010, the patient had recovered. The reporter considered the large erythematous rash to be an other important medical event. This is one of several reports received from the same source. No further information is available.
Sore arm; Headache; Fatigue; Pregnancy at the time of vaccination: Yes; Vaccine administration date: 26Aug2021 at 09:00; Last menstrual date: 03Jan2021; This is a spontaneous report from a contactable consumer, the patient. A 21-year-old 33 weeks-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 26Aug2021 at 09:00 (at the age of 21-years-old) as a single dose for COVID-19 immunisation. The last menstrual date of the patient was on 03Jan2021. The delivery date of the patient was reported as 14Oct2021. Medical history included asthma. Prior to the vaccination, the patient was not diagnosed with COVID-19. It was reported that the patient received other vaccines within four weeks, prior to the COVID-19 vaccine and concomitant vaccines included tetanus vaccine toxoid, diphtheria vaccine toxoid, pertussis vaccine acellular (TDAP) on 11Aug2021. The patient previously received codeine (MANUFACTURER UNKNOWN) for an unknown indication and experienced drug allergy. On 26Aug2021 at 18:00, the patient had sore arm, headache and fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm, headache and fatigue was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous case was reported by a patient and describes the occurrence of PAIN (aches) and SOMNOLENCE (she felt sleepy for about 3 or 4 days.) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concurrent medical conditions included Bee sting hypersensitivity (Allergic to Bumblebees). In April 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced PAIN (aches) and SOMNOLENCE (she felt sleepy for about 3 or 4 days.). In 2021, PAIN (aches) and SOMNOLENCE (she felt sleepy for about 3 or 4 days.) had resolved. Patient's date of birth was reported as Jul 1941. Patient was under a lot of concomitant and regular medications, but there were a lot of them and she could not provide names. After first dose in 2021 and second dose in Apr 2021 patient experienced a few aches, and felt sleepy for about 3 or 4 days. Patient had no medical history related to mentioned AE and both acute and chronic illnesses at the time of vaccination. The Adverse event did not cause patient to seek medical care. The patient did not experience a similar event in the past. No treatment had been given for her symptoms. This case was linked to MOD-2022-635784, MOD-2022-635787 (Patient Link).
Approx 3-4 hours after injection: Sore throat and headache began, low energy levels.  Approximately 12 hours after injection: Runny nose and sneezing began
I had flu like symptoms, fever, chills muscle and nerve pain, soreness, pain in the fingers sand toes, headache in back of eyes and just pain all over. And just being tired and unable to really function. It was really bad 24 hours after the vaccine.
pt came 2 days p/vax reporting pain/redness in lt arm where DTP vax was given;tenderness to palpation & warm;tx atarax;erythema around inj site, fever, pain;MD to r/o cellulitis;
Death, adverse event occurred outside of the hospital and outside of observation window. Event was reported via employee to hospital.